Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-6-7
pubmed:abstractText
Chemerin is a new adipokine involved in in vitro adipogenesis and insulin resistance and associates with body mass index (BMI) in vivo.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1945-7197
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2892-6
pubmed:meshHeading
pubmed-meshheading:20375212-Adipokines, pubmed-meshheading:20375212-Adipose Tissue, pubmed-meshheading:20375212-Adult, pubmed-meshheading:20375212-Anthropometry, pubmed-meshheading:20375212-Bariatric Surgery, pubmed-meshheading:20375212-Biological Markers, pubmed-meshheading:20375212-Chemokines, pubmed-meshheading:20375212-Cholesterol, pubmed-meshheading:20375212-Fatty Liver, pubmed-meshheading:20375212-Female, pubmed-meshheading:20375212-Hepatitis, pubmed-meshheading:20375212-Humans, pubmed-meshheading:20375212-Insulin Resistance, pubmed-meshheading:20375212-Leukocyte Count, pubmed-meshheading:20375212-Lipoproteins, HDL, pubmed-meshheading:20375212-Liver, pubmed-meshheading:20375212-Liver Cirrhosis, pubmed-meshheading:20375212-Longitudinal Studies, pubmed-meshheading:20375212-Macrophages, pubmed-meshheading:20375212-Obesity, Morbid, pubmed-meshheading:20375212-Triglycerides, pubmed-meshheading:20375212-Weight Loss
pubmed:year
2010
pubmed:articleTitle
Chemerin correlates with markers for fatty liver in morbidly obese patients and strongly decreases after weight loss induced by bariatric surgery.
pubmed:affiliation
Institute of Clinical Biochemistry and Pathobiochemistry, German Diabetes Center, Auf'm Hennekamp 65, 40225 Düsseldorf, Germany. henrike.sell@ddz.uni-duesseldorf.de
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't